Side-by-side financials for ABOS and BNTX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ABOS | BNTX |
|---|---|---|
| Market cap | - | $22.64 B |
| US-listed rank | - | #570 |
| Net income (latest FY) | -$121.33M | - |
| SEC filings | 336 | 548 |
Full pages: Acumen Pharmaceuticals, Inc. and BioNTech SE, or browse the full rankings.